Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT02470169

Unknown

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis

Subfertility
NCT02659384

Completed

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Ovarian Neoplasms
NCT01243944

Completed

Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)

Polycythemia Vera
NCT01316068

Unknown

Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients (Soften)

Diabetic Nephropathy | Albuminuria
NCT07389057

Recruiting

Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

Malaria Infection | Malaria Asymptomatic Parasitaemia | Malaria Falciparum | Malaria Transmission
NCT07328438

Not yet recruiting

Diagnosis Disclosure Support for Caregivers of Children With Autism

Autism Spectrum Disorder
NCT06013046

Recruiting

Wheelchair User Physical Activity Training Intervention to Enhance Cardiometabolic Health (WATCH)

Physical Disability
NCT07228637

Active, not recruiting

Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer (PERSIST)

Testicular Cancer
NCT03506867

Enrolling by invitation

Healthy People Initiative (HPI) (HPI)

Substance Use Disorders | Nicotine Dependence
NCT07535333

Not yet recruiting

Exercise-Targeted Smart Lifestyle Management

Metabolic Syndrome | M-health | Lifestyle Alteration | Lifestyle (Sedentary Behavior and Physical Activity) | Overweight , Obesity
NCT05534243

Recruiting

The ED-AWARENESS-2 Trial (ED-AWARENES II)

PTSD | Intubation Complication | Mechanical Ventilation | Awareness
NCT05344742

Not yet recruiting

A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors

Advanced Solid Tumor
NCT06587347

Not yet recruiting

Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke (TREND-2)

Cerebral Infarction | Acute Stroke | Ischemic Stroke, Acute
NCT06447727

Recruiting

Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

Colorectal Cancer Metastatic
NCT06382519

Recruiting

Thalidomide Therapy for VEOIBD

Inflammatory Bowel Diseases
NCT06112262

Not yet recruiting

Comparison Between Haparin and Herodin in HD

Haemodialysis
NCT06107504

Recruiting

Prevention of Post-sphincterotomy Bleeding

Post-ERCP Bleeding
NCT05864755

Recruiting

HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma

Unrescetable Hepatocellular Carcinoma
NCT05364489

Not yet recruiting

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

Advanced Colorectal Cancer
NCT05355155

Not yet recruiting

Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation

Hepatocellular Carcinoma Recurrent | Post-orthotopic Liver Transplantation
NCT05260619

Recruiting

Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma (PCNSL-LEM)

Central Nervous System Lymphoma
NCT05170594

Recruiting

A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

Ovarian Cancer
NCT02342444

Recruiting

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Trauma | Surgery | Deep Vein Thrombosis (DVT) | Thromboembolic Events
NCT05259150

Enrolling by invitation

The Health for Hearts United Collaborative (HHUC)

Cardiovascular Disease Risk Reduction
NCT03505723

Completed

PeriOperative ISchemic Evaluation-3 Trial (POISE-3)

Venous Thrombosis | Arterial Thrombosis | Perioperative Bleeding
NCT04603937

Terminated

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) (GLIMMER)

Diabetic Macular Edema
NCT05248321

Completed

Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding

Peptic Ulcer Hemorrhage
NCT04655586

Completed

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN)

Covid19
NCT03063762

Completed

Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)

Renal Cell Carcinoma
NCT03690947

Completed

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

Diabetic Macular Edema
NCT03082209

Completed

A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies

Cancer | Advanced Solid Tumors | Hematologic Malignancies
NCT00819780

Completed

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Metastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon Cancer
NCT02077166

Completed

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma
NCT03862755

Completed

Chemoprophylaxis Plus Early Ambulation

Pulmonary Embolism | Thoracic Surgery
NCT00000812

Completed

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

HIV Infections
NCT03433144

Withdrawn

The Effects of Tranexamic Acid on Blood Loss During Orthognathic Surgery (TXA-OMFS)

Orthognathic Surgery | Tranexamic Acid
NCT02060305

Terminated

Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis

Hemophilia | Synovitis
NCT00202644

Completed

A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients

Thrombocythemia, Hemorrhagic
NCT01468844

Completed

Minocycline to Treat Central Retinal Vein Occlusion

Retinal Vein Occlusion
NCT03706339

Completed

Reducing Blood Loss During Cesarean Section by Topical Versus IV Tranexamic Acid

Cesarean Section Complications
NCT03247673

Completed

To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin

Healthy
NCT03573986

Terminated

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Recurrent Glioblastoma
NCT02188576

Completed

The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery

Craniosynostosis
NCT03946826

Completed

A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail Psoriasis

Nail Psoriasis
NCT02713204

Completed

Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection (ONYX)

Neovascular Age-Related Macular Degeneration
NCT00038701

Terminated

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

Pancreatic Neoplasms
NCT02712008

Completed

Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema (RUBY)

Diabetic Macular Edema
NCT03590444

Completed

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

Diabetic Retinal Edema
NCT03588494

Unknown

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Quality of Life
NCT01223235

Completed

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Ovarian Cancer | Peritoneal Cancer | Fallopian Tubes Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations